NCT06004479

Brief Summary

Before infants are born, they depend on their mother to provide the nutrients necessary to grow and develop, such as iron, folic acid, iodine and other vitamins and minerals. Pregnant people also rely on good nutrition to support their own health. In addition to essential nutrients, vitamins, and minerals, there are other natural components found in fruits and vegetables, called phytochemicals, that may support maternal and fetal health during pregnancy. While more is known about the role of phytochemicals in adult health, surprisingly little is known about phytochemical nutrition during pregnancy. This study focuses on a group of phytochemicals, called carotenoids, during pregnancy. The study will determine if and why levels of carotenoids in the body change across the course of pregnancy. Understanding carotenoid nutrition during pregnancy will improve the understanding ofnutrition needs of expectant mothers and their infants. To study these questions, both health pregnant and non-pregnant female adults will report on their dietary intake and participate in body measurements, health surveys, and carotenoid measurements of eyes, skin, and blood at time points corresponding with the first, second, and third trimesters of pregnancy as well as post-partum.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 14, 2022

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

May 12, 2023

Completed
3 months until next milestone

First Posted

Study publicly available on registry

August 22, 2023

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 12, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 12, 2024

Completed
Last Updated

December 27, 2024

Status Verified

December 1, 2024

Enrollment Period

2.2 years

First QC Date

May 12, 2023

Last Update Submit

December 20, 2024

Conditions

Keywords

carotenoidsskin carotenoidscognitive functionpregnancy nutritionmacular carotenoids

Outcome Measures

Primary Outcomes (4)

  • Serum Total Carotenoid Concentrations - 1st Trimester Equivalent

    Sum of all major carotenoid species in serum collected from fasting participant.

    1st Trimester Equivalent: 8 weeks 0 days-13 weeks 6 days gestation (Week 0 if non-pregnant)

  • Serum Total Carotenoid Concentrations - 2nd Trimester Equivalent

    Sum of all major carotenoid species in serum collected from fasting participant.

    2nd Trimester Equivalent: 22 weeks 0 days-23 weeks 6 days gestation (or week 11-12 if non-pregnant)

  • Serum Total Carotenoid Concentrations - 3rd Trimester Equivalent

    Sum of all major carotenoid species in serum collected from fasting participant.

    3rd Trimester Equivalent: 32 weeks 0 days -33 weeks 6 days weeks gestation (week 22-23 if non-pregnant)

  • Serum Total Carotenoid Concentrations - Post-partum

    Sum of all major carotenoid species in serum collected from fasting participant.

    Post-partum Equivalent: 7 weeks 0 days - 8 weeks 6 days post-partum (weeks 36-37 if non pregnant)

Secondary Outcomes (8)

  • Skin Carotenoid Concentrations - 1st Trimester Equivalent

    1st Trimester Equivalent: 8 weeks 0 days -13 weeks 6 days gestation (Week 0 if non-pregnant)

  • Macular pigment optical density - 1st Trimester Equivalent

    1st Trimester Equivalent: 8 weeks 0 days - 13 weeks 6 days gestation (Week 0 if non-pregnant)

  • Skin Carotenoid Concentrations - 2nd Trimester Equivalent

    2nd Trimester Equivalent: 22 weeks 0d - 23 weeks 6 days gestation (or week 11-12 if non-pregnant)

  • Macular pigment optical density - 2nd Trimester Equivalent

    2nd Trimester Equivalent: 22 weeks 0 days - 23 weeks 6 days gestation (or week 11-12 if non-pregnant)

  • Skin Carotenoid Concentrations - 3rd Trimester Equivalent

    3rd Trimester Equivalent: 32 weeks 0 days - 33 weeks 6 days weeks gestation (week 22-23 if non-pregnant)

  • +3 more secondary outcomes

Other Outcomes (22)

  • Subjective memory function (MAC-Q Score) - 1st Trimester Equivalent

    1st Trimester Equivalent: 8 weeks 0 days-13 weeks 6 days gestation(Week 0 if non-pregnant)

  • Subjective memory function (MAC-Q Score) - 2nd Trimester Equivalent

    2nd Trimester Equivalent: 22 weeks 0 days - 23 weeks 6 days gestation (or week 11-12 if non-pregnant)

  • Subjective memory function (MAC-Q Score) - 3rd Trimester Equivalent

    3rd Trimester Equivalent: 32 weeks 0 days - 33 weeks 6 days weeks gestation (week 22-23 if non-pregnant)

  • +19 more other outcomes

Study Arms (2)

Pregnant

Adult females between 18-40 years old who have a confirmed pregnancy.

Other: Carotenoid IntakeOther: Serum carotenoid concentration

Non-pregnant

Adult females between 18-40 years old who do not have a confirmed pregnancy.

Other: Carotenoid IntakeOther: Serum carotenoid concentration

Interventions

Carotenoid intake assess by 24 hour dietary recalls

Non-pregnantPregnant

Serum total carotenoid concentration

Non-pregnantPregnant

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Healthy adults are recruited from the community of the greater Houston, TX metropolitan area.

You may qualify if:

  • Pregnant group
  • a pregnancy confirmed by positive pregnancy test and/or ultrasound
  • pre-pregnancy BMI 18.5-29.9 kg/m\^2
  • can speak, read, and understand English
  • agrees to take the prescribed daily prenatal multivitamin as recommended by their licensed prenatal healthcare provider throughout the study.
  • Non-pregnant group
  • current BMI that is lean 18.5-29.9 kg/m\^
  • can speak, read, and understand English
  • agrees to continue taking any daily multivitamins or supplements throughout the study
  • consumes alcohol moderately as outlined by current guidelines.
  • Infants
  • born at term (37 weeks gestation or more)
  • if infant was one of multiple births, only one sibling may be enrolled.

You may not qualify if:

  • Metabolic, kidney, liver, digestive, or malabsorptive disorders with special dietary recommendations for the adult female or infant
  • currently uses tobacco, or drugs; consumes alcohol beyond current recommendations (zero in pregnancy, 1 drink daily average for non-pregnant)
  • adult female currently taking any isolated carotenoid supplements or high carotenoid (\>2 mg/d) supplements
  • adult female currently consumes an exclusively vegan or vegetarian diet
  • adult female uses medications that interfere with dietary fat absorption
  • adult female has history of endocrine disorders requiring hormone administration (with the exception of medically managed hypothyroidism).
  • pregnant adult female has been informed by her doctor that she will need to take hormones during her pregnancy
  • adult female has current vision condition or disease that prevents them from seeing clearly regardless of corrective lenses.
  • adult female is currently lactating at enrollment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine

Houston, Texas, 77030, United States

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

serum, human milk

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 12, 2023

First Posted

August 22, 2023

Study Start

September 14, 2022

Primary Completion

December 12, 2024

Study Completion

December 12, 2024

Last Updated

December 27, 2024

Record last verified: 2024-12

Locations